Vazyme (688105.SH) is a global technology and service provider that dedicated to the design, manufacture, and application of bioactive proteins and continuously expands the application fields of core technologies in life science, in vitro diagnostics, bio-medicine, and others. To meet the varying needs of our customers and partners, we have developed over 600 types of genetically engineered recombinant enzymes and over 2,500 types of high-performance materials and over 2,000 end products. While remaining steadfast to high quality standards, producing all core materials in-house and adhering to GMP quality control standards, we endeavor to maintain a stable and sufficient supply for global customers by establishing subsidiary companies and local warehouses. Currently, Vazyme has served customers in over 60 countries and regions with global subsidiary companies in the USA, Canada, Indonesia, Singapore, Germany, UK, Australia, South Korea and Hungary.
Our mission is to empower our customers to advance the innovation of science and health. Moving forward, we remain steadfastly committed to enhancing public health, helping humanity overcome major illnesses, and fostering collaborations towards a healthier future.
Company Details
- Employees
- 196
- Founded
- -
- Address
- Red Maple Hi-Tech Industry Park, Nanjing, Prc, Nanjing,jiangsu 210033,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vazyme.com+
- HQ
- Nanjing, Jiangsu
Vazyme Questions
Vazyme's website is http://www.vazyme.com+
Vazyme's LinkedIn profile is https://cn.linkedin.com/company/vazyme
Vazyme has
196 employees.
View email and phone details for 196
employees at Vazyme.
Vazyme's industry is
Biotechnology Research
Vazyme's top competitors are
Gsk,
Getein Biotech, Inc.,
Roche,
Pfizer,
Illumina,
Genscript,
Era Biology,
Astrazeneca,
Thermo Fisher Scientific,
Vazyme Medical.
Vazyme's categories are Biotechnology Research
Vazyme's founding year is 2012
